TY - JOUR
T1 - A comparison of the effect of patient-specific versus weight-based protocols to treat vaso-occlusive episodes in the emergency department
AU - Tanabe, Paula
AU - Ibemere, Stephanie
AU - Pierce, Ava E.
AU - Freiermuth, Caroline E.
AU - Bosworth, Hayden B.
AU - Yang, Hongqui
AU - Osunkwo, Ifeyinwa
AU - Paxton, James H.
AU - Strouse, John J.
AU - Miller, Joseph
AU - Paice, Judith A.
AU - Veeramreddy, Padmaja
AU - Kavanagh, Patricia L.
AU - Wilkerson, R. Gentry
AU - Hughes, Robert
AU - Barnhart, Huiman X.
N1 - Publisher Copyright:
© 2023 Society for Academic Emergency Medicine.
PY - 2023/12
Y1 - 2023/12
N2 - Background: Vaso-occlusive crises (VOCs) cause debilitating pain and are a common cause of emergency department (ED) visits, for people with sickle cell disease (SCD). Strategies for achieving optimal pain control vary widely despite evidence-based guidelines. We tested existing guidelines and hypothesized that a patient-specific pain protocol (PSP) written by their SCD provider may be more effective than weight-based (WB) dosing of parenteral opiate medication, in relieving pain. Methods: This study was a prospective, randomized controlled trial comparing a PSP versus WB protocol for patients presenting with VOCs to six EDs. Patients were randomized to a PSP or WB protocol prior to an ED visit. The SCD provider wrote their protocol and placed it in the electronic health record for future ED visits with VOC exclusion criteria that included preexisting PSP excluding parenteral opioid analgesia or outpatient use of buprenorphine or methadone or highly suspected for COVID-19. Pain intensity scores, side effects, and safety were obtained every 30 min for up to 6 h post–ED bed placement. The primary outcome was change in pain intensity score from placement in an ED space to disposition or 6 h. Results: A total of 328 subjects were randomized; 104 participants enrolled (ED visit, target n = 230) with complete data for 96 visits. The study was unable to reach the target sample size and stopped early due to the impact of COVID-19. We found no significant differences between groups in the primary outcome; patients randomized to a PSP had a shorter ED length of stay (p = 0.008), and the prevalence of side effects was low in both groups. Subjects in both groups experienced both a clinically meaningful and a statistically significant decrease in pain (27 mm on a 0- to 100-mm scale). Conclusions: We found a shorter ED length of stay for patients assigned to a PSP. Patients in both groups experienced good pain relief without significant side effects.
AB - Background: Vaso-occlusive crises (VOCs) cause debilitating pain and are a common cause of emergency department (ED) visits, for people with sickle cell disease (SCD). Strategies for achieving optimal pain control vary widely despite evidence-based guidelines. We tested existing guidelines and hypothesized that a patient-specific pain protocol (PSP) written by their SCD provider may be more effective than weight-based (WB) dosing of parenteral opiate medication, in relieving pain. Methods: This study was a prospective, randomized controlled trial comparing a PSP versus WB protocol for patients presenting with VOCs to six EDs. Patients were randomized to a PSP or WB protocol prior to an ED visit. The SCD provider wrote their protocol and placed it in the electronic health record for future ED visits with VOC exclusion criteria that included preexisting PSP excluding parenteral opioid analgesia or outpatient use of buprenorphine or methadone or highly suspected for COVID-19. Pain intensity scores, side effects, and safety were obtained every 30 min for up to 6 h post–ED bed placement. The primary outcome was change in pain intensity score from placement in an ED space to disposition or 6 h. Results: A total of 328 subjects were randomized; 104 participants enrolled (ED visit, target n = 230) with complete data for 96 visits. The study was unable to reach the target sample size and stopped early due to the impact of COVID-19. We found no significant differences between groups in the primary outcome; patients randomized to a PSP had a shorter ED length of stay (p = 0.008), and the prevalence of side effects was low in both groups. Subjects in both groups experienced both a clinically meaningful and a statistically significant decrease in pain (27 mm on a 0- to 100-mm scale). Conclusions: We found a shorter ED length of stay for patients assigned to a PSP. Patients in both groups experienced good pain relief without significant side effects.
UR - http://www.scopus.com/inward/record.url?scp=85176728003&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85176728003&partnerID=8YFLogxK
U2 - 10.1111/acem.14805
DO - 10.1111/acem.14805
M3 - Article
C2 - 37731093
AN - SCOPUS:85176728003
SN - 1069-6563
VL - 30
SP - 1210
EP - 1222
JO - Academic Emergency Medicine
JF - Academic Emergency Medicine
IS - 12
ER -